Global Gastrointestinal/GI Stent Market, By Product (Pancreatic Stents, Biliary Stents, Colonic Stents, Duodenal Stents and Oesophageal Stents), Material (Plastic Stents, Self-Expanding Metal Stents and Covered Self-Expandable Metallic Stents), Type (Anti-Migratory Stents, Drug-Eluting Stents, Radioactive Stents, Anti-Reflux Stents, Shape-Modified Stents and Biodegradable Stents), Disease Type (Gastrointestinal Cancer, Biliary Diseases and Inflammatory Bowel Diseases), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centre and Others) – Industry Trends and Forecast to 2030.
Gastrointestinal/GI Stent Market Analysis and Size
The incidence of esophageal strictures can vary depending on various causes. The incidence of esophageal strictures due to GERD is estimated to be around 1 in 1,000 individuals per year in the general population. However, this can increase in certain subgroups, such as those with severe or long-standing GERD symptoms. Eosinophilic esophagitis (EoE) is another cause of esophageal strictures, particularly in children and young adults. The incidence of EoE has been increasing in recent years but remains relatively rare, estimated to affect around 1 in 2,000 individuals.
Data Bridge Market Research analyses that the global gastrointestinal/GI stent market which was USD 482.14 million in 2022, is expected to reach USD 701.35 million by 2030, and is expected to undergo a CAGR of 5.5% during the forecast period of 2023 to 2030. “Oesophageal Stents” dominates the product segment of the global gastrointestinal/GI stent market owing to the growing demand for better methods for treatment in patients. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Gastrointestinal/GI Stent Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, and Pricing in USD
|
|
Segments Covered
|
Product (Pancreatic Stents, Biliary Stents, Colonic Stents, Duodenal Stents and Oesophageal Stents), Material (Plastic Stents, Self-Expanding Metal Stents and Covered Self-Expandable Metallic Stents), Type (Anti-Migratory Stents, Drug-Eluting Stents, Radioactive Stents, Anti-Reflux Stents, Shape-Modified Stents and Biodegradable Stents), Disease Type (Gastrointestinal Cancer, Biliary Diseases and Inflammatory Bowel Diseases), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centre and Others)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East and Africa
|
|
Market Players Covered
|
BD (U.S.), Boston Scientific Corporation (U.S.), Medtronic (Ireland), Terumo Corporation (Japan), Johnson & Johnson Services, Inc. (U.S.), 3M (U.S.), Smith & Nephew (U.K.), Diagmed Healthcare (India), Medline Industries, Inc. (U.S.), Baxter (U.S.), B. Braun Melsungen AG (Germany), Danaher (U.S.), GENERAL ELECTRIC COMPANY (U.S.), CONMED Corporation. (U.S.), HOBBS MEDICAL INC. (U.S.), Olympus Corporation (Japan), Cantel Medical. (U.S.), ConvaTec Inc. (U.K.), M.C. Johnson Company, Inc. (U.S.) and Merit Medical Systems (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Gastrointestinal (GI) stent is a medical device used to treat obstructions or strictures in the gastrointestinal tract. It is a tubular structure typically made of metal or a combination of metal and synthetic materials. GI stents are designed to be inserted endoscopically or surgically into the affected area of the digestive system to provide support and maintain patency (openness) of the passage. GI stents can be self-expandable or balloon-expandable, depending on the specific type and location of the obstruction. The choice of stent type and size is determined by the individual patient's condition and the judgment of the treating healthcare professional.
Global Gastrointestinal/GI Stent Market Dynamics
Drivers
- Increasing Prevalence of Gastrointestinal Disorders
The rising incidence of gastrointestinal disorders such as colorectal cancer, esophageal cancer, gastric outlet obstruction, and inflammatory bowel disease (IBD) is driving the demand for GI stents. These conditions often require stent placement to relieve symptoms and improve the patient's quality of life.
- Minimally Invasive Procedures
GI stent placement is often performed using minimally invasive techniques, such as endoscopy or laparoscopy. These procedures offer benefits such as shorter hospital stays, faster recovery times, and reduced morbidity compared to traditional open surgeries. The increasing preference for minimally invasive procedures is driving the demand for GI stents.
Opportunities
- Technological Advancements in GI Stents
Continued research and development in stent design, materials, and delivery systems present opportunities for innovation and improvement in GI stent technology. Advancements in biodegradable stents, drug-eluting stents, and personalized stent solutions can enhance patient outcomes and drive market growth.
- Expansion of Endoscopic Procedures
Endoscopic procedures, including endoscopic stent placement, are becoming increasingly common for the treatment of gastrointestinal disorders. The expansion of endoscopic techniques, such as endoscopic ultrasound (EUS) and endoscopic retrograde cholangiopancreatography (ERCP), provides opportunities for GI stent manufacturers to develop specialized stents for these procedures.
Restraints/Challenges
- Limited Reimbursement and Pricing Pressures
Reimbursement policies and pricing pressures can impact the adoption and utilization of GI stents. In some regions, reimbursement for certain indications or specific stent types may be limited or subject to strict criteria. Pricing pressures can also arise from competition, healthcare budget constraints, and negotiations with payers. Manufacturers need to navigate these challenges to ensure market access and profitability.
- Availability of Alternative Treatment Options
In certain cases, alternative treatment options may be available for gastrointestinal conditions, such as surgical interventions or other minimally invasive procedures. The availability of these alternatives can limit the demand for GI stents and pose a challenge for market growth. Manufacturers need to demonstrate the clinical and economic benefits of stent placement compared to alternative treatments.
This global gastrointestinal/GI stent market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global gastrointestinal/GI stent market contact Data Bridge Market Research for an analyst brief, our team will help you make an informed market decision to achieve market growth.
Recent Developments
- In December 2020, Boston Scientific announced the launch of its WallFlex Biliary RX Fully Covered Stent with Controlled Release Technology in the United States. The stent is designed to provide controlled release of a drug to help prevent tissue overgrowth.
- In November 2020, Cook Medical received FDA clearance for its Evolution® Controlled-Release Esophageal Stent. The stent features a dual-layer design that aims to reduce the risk of tissue overgrowth and migration
Global Gastrointestinal/GI Stent Market Scope
The global gastrointestinal/GI stent market is segmented on the basis of product, material, type, disease type, and end users. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Pancreatic Stents
- Biliary Stents
- Colonic Stents
- Duodenal Stents
- Oesophageal Stents
Material
- Plastic Stents
- Self-Expanding Metal Stents
- Stainless Steel Stents
- Nitinol Stents
- Others
- Covered Self-Expandable Metallic Stents
Type
- Anti-Migratory Stents
- Drug-Eluting Stents
- Radioactive Stents
- Anti-Reflux Stents
- Shape-Modified Stents
- Biodegradable Stents
Disease Type
- Gastrointestinal Cancer
- Colorectal Cancer
- Pancreatic Cancer
- Stomach Cancer
- Oesophageal Cancer
- Biliary Diseases
- Inflammatory Bowel Diseases
End Users
- Hospitals
- Ambulatory Surgical Centre
- Specialty Clinics
- Others
Global Gastrointestinal/GI Stent Market Regional Analysis/Insights
The global gastrointestinal/GI stent market is analyzed and market size insights and trends are provided by country, product, material, type, disease type, and end users as referenced above.
The countries covered in the global gastrointestinal/GI stent market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East and Africa
North America dominates the global gastrointestinal/GI stent market because of the strong base of healthcare facilities, the strong presence of major players in the market, the extraordinary healthcare infrastructure, the prevailing sophisticated level of healthcare facilities and surge in the cases of cancer.
Asia-Pacific is expected to witness significant growth in the global gastrointestinal/GI stent market during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote healthcare, the rising health awareness among the people and growing demand for advanced medical technology for diagnosis and treatment procedures, the large population pool, and the growing demand for quality healthcare in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends, and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The global gastrointestinal/GI stent market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the global gastrointestinal/GI stent market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the global gastrointestinal/GI stent market. The data is available for historic period 2015-2020.
Competitive Landscape and Gastrointestinal/GI Stent Market Share Analysis
The global gastrointestinal/GI stent market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, application dominance. The above data points provided are only related to the companies' focus related to the global gastrointestinal/GI stent market.
Some of the major players operating in the global gastrointestinal/GI stent market are:
- BD (U.S.)
- Boston Scientific Corporation (U.S.)
- Medtronic (Ireland)
- Terumo Corporation (Japan)
- Johnson & Johnson Services, Inc. (U.S.)
- 3M (U.S.)
- Smith & Nephew (U.K.)
- Diagmed Healthcare (India)
- Medline Industries, Inc. (U.S.)
- Baxter (U.S.)
- B. Braun Melsungen AG (Germany)
- Danaher (U.S.)
- GENERAL ELECTRIC COMPANY (U.S.)
- CONMED Corporation. (U.S.)
- HOBBS MEDICAL INC. (U.S.)
- Olympus Corporation (Japan)
- Cantel Medical. (U.S.)
- ConvaTec Inc. (U.K.)
- M.C. Johnson Company, Inc. (U.S.)
- Merit Medical Systems (U.S.)
SKU-